TOT BIOPHARM INTL CO LTD revenue breakdown overview

TOT BIOPHARM INTL CO LTD revenue for the last year amounted to 1.17 B HKD, the most of which — 1.19 B HKD — came from its highest performing source at the moment, Anti-tumor Drugs and Self-developed Biological Drugs, the year earlier bringing 862.59 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought TOT BIOPHARM INTL CO LTD 1.18 B HKD, and the year before that — 862.59 M HKD.